Well, I certainly do not dislike TC, in fact I think he is a fine chap at Ariad. It's just that after 21 years at the feeding trough of Ariad, and with three clinical drug trial design failures, it is time to re-start the process. Yes, even with '788, it is time to bring in someone else before it is too late. Maybe in a corroborative relationship. They only like to use Texas sized doses it appears.
That $10 offer was certainly not real. You got to keep than in mind. Was a trial balloon..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.